How could Europe-wide drug shortages affect the National Pharmacy Association?
Drug shortages increase patient safety risks and professional pressure for National Pharmacy Association members The widespread drug shortages, driven by production limitations and high demand, are posing severe risks to patient safety and increasing operational strain on pharmacies. A survey conducted by the National Pharmacy Association found that 96% of the around 6,000 independent community pharmacies surveyed felt the situation posed a serious risk to their patients. Furthermore, 83% of pharmacy teams have reported facing abuse or anger from patients due to medicine unavailability. In response, the National Pharmacy Association is urging the government to convene an urgent taskforce involving manufacturers, wholesalers, and clinicians to tackle the supply chain issue.
- Effect
- Strong negative
- How direct
- Stated in the reporting
- When
- Over the long term
- The story
- Gone quiet
How it reaches National Pharmacy Association
-
Drug shortages are widespread across Europe, affecting common medicines such as painkillers and blood pressure medication. The European Medicines Agency noted a long-term shortage of Creon due to production limitations and high demand. Separately, an insulin shortage in Pakistan was linked to a German manufacturer halting supplies, an issue whose impact was also noted in Europe.
The full event2independent outlets -
The Europe-wide drug shortages, which include medicines like Ramipril and Creon, are forcing pharmacies to spend significant time hunting stock and liaising with GP teams instead of focusing on patient care. This disruption, coupled with the lack of necessary medicines, has led the National Pharmacy Association to report that 96% of its surveyed pharmacies feel the situation poses a serious risk to patient safety.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- gazettelive.co.uk Jun 1
-
organization
Everything about National Pharmacy Association
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- The National Pharmacy Association surveyed around 6,000 independent community pharmacies in the UK.gazettelive.co.uk
- 96% of pharmacies surveyed felt the situation posed a serious risk to the safety of their patients.gazettelive.co.uk
- Some 83% of pharmacy teams have faced abuse or anger from patients due to a prescribed medicine being unavailable.gazettelive.co.uk
- The production limitations for Creon, a drug for cystic fibrosis and pancreatic cancer, may go on well into 2027.gazettelive.co.uk
Why it matters
The National Pharmacy Association represents a critical frontline service in the healthcare system. The severity of these shortages—which leaders describe as some of the worst seen—directly impacts the ability of these pharmacies to provide safe and timely care, placing immense pressure on pharmacy teams and GPs alike.
This issue is not isolated; the NPA is calling for a systemic response, urging the government to convene an emergency taskforce. This reflects a broader concern across the medicines market regarding increasing volatility and the need to resolve underlying supply chain issues to protect patient access to essential medications.
What we don't know yet
- Will the government agree to convene the urgent taskforce requested by the National Pharmacy Association?
- What legislative changes, such as allowing simple substitutions, might be implemented to ease the burden on pharmacists?
Is this still moving?
- Reports
- 2
- Developments
- 6
- Repetition
- 0%
What would change this answer
— Other considerations
Beyond this explainer
Explore connected ideas
Each opens in Related concepts: what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Who else could feel it
Other possible ripples from the same event.
- governmentLikelyDrug shortages prompt calls for government taskforce and legislative change
- companyPossibleDrug shortages could strain pharmaceutical companies' operations and supply chains in Europe
- European CommissionPossibleDrug shortages may force the European Commission to coordinate EU supply chain solutions
Reporting
- gazettelive.co.ukJun 1
- tribune.com.pkOct 24
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.